Electra Therapeutics
ETRA8.8402.96% ( -0.270 )
已收盤: 11月13日 16:00:00 (美東)股東
全部股東
股東類型
- 創投/私募39.25%
- 公眾及其他34.14%
- 對沖基金8.70%
- 機構投資者6.57%
- 其他11.34%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
OrbiMed Advisors LLC | 11.87% | 744.99 萬 | -- | +744.99 萬 | |
Westlake Village BioPartners | 10.11% | 634.75 萬 | -- | +634.75 萬 | 30/09/2026 |
Redmile Group, LLC | 8.70% | 546.29 萬 | -- | +546.29 萬 | 21/09/2026 |
Eqt Fund Management S.à R.L. | 6.05% | 379.53 萬 | -- | +379.53 萬 | 30/09/2026 |
EQT Life Sciences | 6.05% | 379.53 萬 | -- | +379.53 萬 | 21/09/2026 |
Lsp 7 Cooperatief U.A. | 6.05% | 379.53 萬 | -- | +379.53 萬 | 21/09/2026 |
New Leaf Venture Partners, LLC | 5.18% | 324.83 萬 | -- | +324.83 萬 | 18/09/2026 |
Sanofi | 3.92% | 246.19 萬 | -- | +246.19 萬 | 30/09/2026 |
Jefferies Financial Group Inc. | 3.58% | 224.43 萬 | -- | +224.43 萬 | 30/09/2026 |
Jennison Associates LLC | 0.80% | 49.94 萬 | -- | +49.94 萬 | 30/09/2026 |
Quehuong DongPresident, CEO & Director | 0.73% | 45.55 萬 | -- | +45.55 萬 | 21/09/2026 |
T. Rowe Price Group, Inc. | 0.67% | 41.76 萬 | -- | +41.76 萬 | 30/09/2026 |
Nancy StaglianoIndependent Chair | 0.41% | 25.56 萬 | -- | +25.56 萬 | 21/09/2026 |
Vanguard Capital Management, LLC | 0.36% | 22.52 萬 | -- | +22.52 萬 | 30/09/2026 |
Victory Capital Management Inc. | 0.28% | 17.77 萬 | -- | +17.77 萬 | 30/09/2026 |
Ensign Peak Advisors, Inc. | 0.25% | 15.84 萬 | -- | +15.84 萬 | 30/09/2026 |
Columbia Management Investment Advisers, LLC | 0.20% | 12.79 萬 | -- | +12.79 萬 | 30/09/2026 |
Monashee Investment Management, LLC | 0.16% | 10.00 萬 | -- | +10.00 萬 | 30/09/2026 |
Graham ParryChief Scientific Officer | 0.14% | 8.55 萬 | -- | +8.55 萬 | 21/09/2026 |
Gary KoeChief Technology Officer | 0.10% | 6.37 萬 | -- | +6.37 萬 | 21/09/2026 |